Clinical trial
Prognostic Impact of Lesion-specific Hemodynamic Index and Disease Characteristics in Patients With Coronary Artery Disease Assessed by Fractional Flow Reserve
NCT05250557 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Impact of Lesion-specific Hemodynamic Index and Disease Characteristics in Patients With Coronary Artery Disease Assessed by Fractional Flow Reserve
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 1, 2021
- Completion date
- December 31, 2026
- Enrollment
- 2,429 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.